August 6, 2025
•
Sarepta.com
Sarepta Therapeutics Announces Second Quarter 2025 Financial Results and Recent Corporate Developments - Sarepta Therapeutics
- ELEVIDYS shipments have resumed for ambulatory individuals living with Duchenne following notification from the U.S. Food and Drug Administration (FDA); continuing to work with FDA on safet…